UBS Group’s Can-Fite BioPharma CANF Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.79K | Buy |
+5,515
| New | +$5.79K | ﹤0.01% | 7813 |
|
|
2024
Q2 | – | Sell |
-2,172
| Closed | -$4.82K | – | 8365 |
|
|
2024
Q1 | $4.82K | Buy |
+2,172
| New | +$4.82K | ﹤0.01% | 6418 |
|
|
2023
Q2 | – | Sell |
-714
| Closed | -$1.64K | – | 7855 |
|
|
2023
Q1 | $1.64K | Sell |
714
-157
| -18% | -$360 | ﹤0.01% | 7588 |
|
|
2022
Q4 | $5.31K | Sell |
871
-865
| -50% | -$5.28K | ﹤0.01% | 7998 |
|
|
2022
Q3 | $13K | Buy |
1,736
+984
| +131% | +$7.37K | ﹤0.01% | 6910 |
|
|
2022
Q2 | $7K | Buy |
752
+34
| +5% | +$316 | ﹤0.01% | 7419 |
|
|
2022
Q1 | $9K | Buy |
+718
| New | +$9K | ﹤0.01% | 7478 |
|
|
2021
Q3 | – | Sell |
-771
| Closed | -$18K | – | 8378 |
|
|
2021
Q2 | $18K | Buy |
+771
| New | +$18K | ﹤0.01% | 6348 |
|
|
2020
Q3 | – | Sell |
-306
| Closed | -$6K | – | 7096 |
|
|
2020
Q2 | $6K | Sell |
306
-553
| -64% | -$10.8K | ﹤0.01% | 6424 |
|
|
2020
Q1 | $11K | Buy |
859
+784
| +1,045% | +$10K | ﹤0.01% | 5943 |
|
|
2019
Q4 | $2K | Buy |
+75
| New | +$2K | ﹤0.01% | 6740 |
|
|
2019
Q1 | – | Sell |
-10
| Closed | -$2K | – | 6874 |
|
|
2018
Q4 | $2K | Buy |
10
+1
| +11% | +$200 | ﹤0.01% | 6855 |
|
|
2018
Q3 | $2K | Sell |
9
-9
| -50% | -$2K | ﹤0.01% | 6799 |
|
|
2018
Q2 | $3K | Buy |
+18
| New | +$3K | ﹤0.01% | 6687 |
|
|
2018
Q1 | – | Sell |
-3
| Closed | -$1K | – | 6890 |
|
|
2017
Q4 | $1K | Sell |
3
-6
| -67% | -$2K | ﹤0.01% | 6712 |
|
|
2017
Q3 | $2K | Buy |
+9
| New | +$2K | ﹤0.01% | 6533 |
|
|
2017
Q1 | – | Sell |
-16
| Closed | -$6K | – | 6677 |
|
|
2016
Q4 | $6K | Buy |
16
+15
| +1,500% | +$5.63K | ﹤0.01% | 6171 |
|
|
2016
Q3 | $1K | Sell |
1
-40
| -98% | -$40K | ﹤0.01% | 6554 |
|
|
2016
Q2 | $16K | Buy |
+41
| New | +$16K | ﹤0.01% | 5570 |
|
|
2015
Q3 | – | Sell |
-35
| Closed | -$11K | – | 6847 |
|
|
2015
Q2 | $11K | Buy |
35
+20
| +133% | +$6.29K | ﹤0.01% | 5912 |
|
|
2015
Q1 | $5K | Buy |
15
+12
| +400% | +$4K | ﹤0.01% | 6166 |
|
|
2014
Q4 | $1K | Buy |
+3
| New | +$1K | ﹤0.01% | 6679 |
|